Company Filing History:
Years Active: 2010-2011
Title: Innovations in Antidepressant Treatment by Silvia Paddock
Introduction
Silvia Paddock is a notable inventor based in Solna, Sweden. She has made significant contributions to the field of mental health through her innovative approaches to antidepressant treatment. With a total of 2 patents, her work focuses on identifying patients at risk of adverse events during treatment and predicting treatment outcomes.
Latest Patents
One of her latest patents is titled "Methods to identify patients at risk of developing adverse events during treatment with antidepressant medication." This invention provides a method for screening patients to identify those more likely to exhibit an increased risk of treatment-emergent suicidal ideation. The method involves obtaining a sample of genetic material from patients and assaying it for the presence of specific genotypes associated with this increased risk. The genotypes are characterized by polymorphisms in genes such as glutamine receptor, ionotropic, kainate 2 (GRIK2) and glutamate receptor ionotropic AMPA 3 (GRIA3).
Another significant patent is "Methods to predict the outcome of treatment with antidepressant medication." This invention outlines a method for determining the outcome of treatment with antidepressant medication in patients. It includes screening patients to identify those with a decreased risk of non-response to treatment by obtaining a sample of genetic material and assaying it for specific genotypes. The genotypes are characterized by polymorphisms in the genes HTR2A, GRIK4, and BCL2.
Career Highlights
Silvia Paddock has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the University of Texas System. Her work has had a profound impact on the understanding and treatment of mental health conditions.
Collaborations
Throughout her career, Silvia has collaborated with esteemed colleagues such as Francis J McMahon and Gonzalo E Laje. These collaborations have further enhanced her research and contributions to the field.
Conclusion
Silvia Paddock's innovative patents and collaborations have significantly advanced the understanding of antidepressant treatment and patient care. Her work continues to influence the field of mental health, providing valuable insights into patient screening and treatment outcomes.